BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17652973)

  • 1. [Monoclonal antibodies, act two: new molecules for new challenges].
    Dutertre CA; Teillaud JL
    J Soc Biol; 2006; 200(4):377-86. PubMed ID: 17652973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What is biotherapy? The monoclonal antibody case].
    Teillaud JL
    Presse Med; 2009 May; 38(5):825-31. PubMed ID: 19282135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
    Gu J; Ghayur T
    Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies, 30 years of success].
    Laffly E; Sodoyer R
    J Soc Biol; 2006; 200(4):325-43. PubMed ID: 17652969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coming of age of engineered multivalent antibodies.
    Nuñez-Prado N; Compte M; Harwood S; Álvarez-Méndez A; Lykkemark S; Sanz L; Álvarez-Vallina L
    Drug Discov Today; 2015 May; 20(5):588-94. PubMed ID: 25757598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular engineering of antibodies for therapeutic and diagnostic purposes.
    Ducancel F; Muller BH
    MAbs; 2012; 4(4):445-57. PubMed ID: 22684311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody therapeutics: history and future.
    Buss NA; Henderson SJ; McFarlane M; Shenton JM; de Haan L
    Curr Opin Pharmacol; 2012 Oct; 12(5):615-22. PubMed ID: 22920732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research and development of next generation of antibody-based therapeutics.
    Li J; Zhu Z
    Acta Pharmacol Sin; 2010 Sep; 31(9):1198-207. PubMed ID: 20694021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-Aided Antibody Design: An Overview.
    Choong YS; Lee YV; Soong JX; Law CT; Lim YY
    Adv Exp Med Biol; 2017; 1053():221-243. PubMed ID: 29549642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection, design, and engineering of therapeutic antibodies.
    Presta LG
    J Allergy Clin Immunol; 2005 Oct; 116(4):731-6; quiz 737. PubMed ID: 16210043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic antibodies: magic bullets hit the target.
    Gura T
    Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular engineering and design of therapeutic antibodies.
    Presta LG
    Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of humanized antibodies as cancer therapeutics.
    Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
    Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Guided Design of Antibodies.
    Caravella JA; Wang D; Glaser SM; Lugovskoy A
    Curr Comput Aided Drug Des; 2010; 6(2):128-38. PubMed ID: 26845329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody engineering for the development of therapeutic antibodies.
    Kim SJ; Park Y; Hong HJ
    Mol Cells; 2005 Aug; 20(1):17-29. PubMed ID: 16258237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The present state of the art in expression, production and characterization of monoclonal antibodies.
    Gaughan CL
    Mol Divers; 2016 Feb; 20(1):255-70. PubMed ID: 26299798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases.
    Irani V; Guy AJ; Andrew D; Beeson JG; Ramsland PA; Richards JS
    Mol Immunol; 2015 Oct; 67(2 Pt A):171-82. PubMed ID: 25900877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.